Following an overview of the pathophysiology and medical consequences of varicose veins, two clinicians who have recently started using this technology to treat patients commented on their experiences. We closed with a panel discussion addressing the US and European market perspective for this procedure and other business related aspects of incorporating this technology into a clinician’s practice.
Panelists & Agenda
Dr. Steve Elias
Director, Center for Vein Disease, Englewood Health Network
Dr. Elias will give an introduction about the pathophysiology and medical consequences of varicose veins.
Professor Mark Whiteley
Executive Chairman, Consultant Venous Surgeon, The Whiteley Clinic
Prof. Whiteley will share his experience using the Theraclion machine.
Dr. Rubén Rodríguez Carvajal
Director, International Vascular and Endovascular Institute (IVEI)
Dr. Rodríguez Carvajal will comment on his experience in Spain.
Chief Executive Officer, Theraclion
Mr. Caumartin will participate in the panel discussion.
Dr. Michel Nuta
Vice President Veins & Chief Medical Officer, Theraclion
Dr. Nuta will participate in the panel discussion.